Rheumatology Journals

Rheumatology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fonnesu C et al. - Familial Mediterranean Fever (FMF) is a hereditary autosomal recessive, autoinflammatory disorder characterized by recurrent, self-limiting episodes of short duration (mean 24–72 h) of fever and serositis. The most severe long-term complication is type AA amyloidosis, principally affecting the kidney and the cause of chronic renal failure. Two types of risk factors, genetic and non-genetic, have been identified for this complication. Currently, the only effective treatment of Familial Mediterranean Fever is the colchicine.

Related Articles

MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations
Rheumatology International, 10/16/09    Relevance Score: 67%

Familial Mediterranean fever gene mutations in the inner northern region of Turkey and genotype-phenotype correlation in children
Journal of Paediatrics and Child Health, 10/27/09    Relevance Score: 65%

Neutrophil-derived S100A12 as novel biomarker of inflammation in Familial Mediterranean Fever
Annals of Rheumatic Diseases, 10/01/09    Relevance Score: 65%

Heart rate variability in familial Mediterranean fever
Rheumatology International, 11/06/09    Relevance Score: 64%

Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behcets disease
Clinical Rheumatology, 10/06/09    Relevance Score: 64%

Today in Autoimmune/Heritable...keeping you current

Is bioptic assurance reasonable in patients with Sjogren’s syndrome
Zeitschrift für Rheumatologie, 12/19/09

Severe autoimmune hemolytic anemia associated with IgM warm auto-antibodies in primary Sjogren's syndrome
International Journal of Rheumatic Diseases, 12/19/09

A diagnosis not to be missed: Behcets disease as a cause of dilated cardiomyopathy in a young Arab male patient
International Journal of Rheumatic Diseases, 12/19/09